The global airway management devices market is projected to reach USD 2.4 Billion by 2028 from USD 1.8 Billion in 2022, at a CAGR of 5.6% during the forecast period. The growth of this market is majorly driven by increasing demand for emergency and intensive care units, increasing growth in healthcare infrastructure development and rising pre-term birth population is supporting the growth of the market. However, dearth of skilled professional for airway management procedures may restrain the market growth during the forecast period.
Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=116806061
Based on type, the airway management devices market has been segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, cricothyrotomy kits, and other airway management devices. The Infraglottic airway management devices segment accounted for the largest market share in 2022. Increasing number of surgical procedures and emergency care is driving the adoption of infraglottic devices in the market.
Based on patient age, the airway management devices market has been categorized into adult patients and pediatric /neonatal patients. In 2022, adult patients segment dominates the segment due to increasing prevalence of chronic diseases in geriatric population.
Based on applications, the airway management devices market is segmented into anesthesia, emergency medicine and others. The anesthesia application segment is expected to observe highest growth rate during the forecast period which can be attributed to the growing need for maintaining a safe breathing passage to decrease the risk of anesthesia-related complications during surgery.
Based on end users, the airway management devices market is segmented into hospitals, ambulatory care settings, home-care settings, and others. Hospital & diagnostic centers observe the highest growth rate during the forecast period attributed to the growing number of emergency care and intensive care beds across hospitals worldwide.
Based on the region segmentation, the airway management devices market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share and expects to dominate the airway management devices market. Growth in the North American market is mainly driven by increasing number of favorable reimbursement policies investments and rising number of acute and ambulatory care settings.
Major Players:
Medtronic (Ireland), ICU Medical, Inc. (US), Teleflex Incorporated (US), Ambu A/S (Denmark), ConvaTec Group Plc (UK), KARL STORZ SE & CO. KG (Germany), Flexicare Group Ltd. (UK), Intersurgical Ltd. (UK), SunMed LLC (US), Vyaire (US), Verathon Inc. (US), Sourcemark LLC (US), VBM Medizintecnik GmBH (Germany), Mercury Enterprises (US), Atos Medical (Sweden), P3 Medical (UK), Henan Tuoren Medical Device Co. Ltd. (China), BOMImed (Canada), Mederen Neotech Ltd. (Israel), and Medis Medical (UK) Ltd.(China), Olympus Corporation (Japan), Armstrong Medical Ltd. (Eakin Healthcare Group) (UK), Nihon Kohden Corporation (Japan) and Shenzen Hugemed Medical Technical Development Co. Ltd. (China)
Recent Developments
In 2022, SunMed Holdings (US) announced a strategic partnership with Securisyn Medical LLC (US) to enhance ventilated patient safety and broader smooth tube and catheter security.
In 2022, Coloplast A/S acquired Atos Medical to add a new chronic business segment – ENT & Respiratory Care, which will run as a separate strategic unit, operating on shared Coloplast infrastructure.
In 2022, ICU Medical, Inc. acquired Smiths Medical (US), which includes a syringe and ambulatory infusion devices, vascular access, and vital care products. When combined with ICU Medical’s existing businesses, it created a leading infusion therapy company.
Content Source:
https://www.marketsandmarkets.com/PressReleases/airway-management-device.asp
https://www.marketsandmarkets.com/ResearchInsight/airway-management-device-market-size-and-share.asp
About MarketsandMarkets™:
MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.
Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.
The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
English
Arabic
Français
Español
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian